Westminster Pharmaceuticals Recalls

2 recalls found for Westminster Pharmaceuticals. Check if any of your products are affected.

HIGHFDA DRUG

Aug 6, 2025

Westminster Pharmaceuticals Recalls Metoprolol Tartrate Tablets Due to Nitrosamine Contamination

Westminster Pharmaceuticals recalled 16,672 bottles of Metoprolol Tartrate Tablets on August 6, 2025. The recall stems from high levels of a harmful nitrosamine, N-nitroso-metoprolol, exceeding the Acceptable Daily Intake. Consumers must stop using the tablets immediately and consult healthcare providers for guidance.

METOPROLOL TARTRATE

CGMP Deviations:

HIGHFDA DRUG

Aug 6, 2025

Westminster Pharmaceuticals Recalls Metoprolol Tartrate Tablets Due to Nitrosamine Hazard

Westminster Pharmaceuticals recalled 4,456 bottles of Metoprolol Tartrate Tablets on August 6, 2025. The recall follows the detection of a nitrosamine, N-nitroso-metoprolol, above acceptable daily intake levels. Consumers should immediately stop using this medication and consult healthcare providers.

Metoprolol Tartrate

CGMP Deviations:

Brand Statistics

Total Recalls

Pages

Related Brands

METOPROLOL TARTRATE Metoprolol Tartrate